Jump Financial’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
Jump Financial's BEAM Position: Q1 2026 in Review
Jump Financial opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 89,386 shares worth $2.13M. The stake represents 0.03% of the portfolio and ranks #628 among its holdings. This is a return to the name: Jump Financial previously reported a position in BEAM as recently as Q3 2025.
Jump Financial first reported a position in BEAM in Q1 2021 and has held it in 11 quarters since. The position peaked at $3.51M in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- Jump Financial held 89,386 shares of Beam Therapeutics worth $2.13M as of Q1 2026.
- Beam Therapeutics was a new Jump Financial position in Q1 2026.
- Beam Therapeutics made up 0.03% of Jump Financial's portfolio in Q1 2026, its #628 holding.
- Jump Financial first reported a position in Beam Therapeutics in Q1 2021 and has held it in 11 quarters since.
- Jump Financial's Beam Therapeutics position peaked at $3.51M in Q3 2025.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.